Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 197

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part II, Item 2
Chunk 197
---
06-30

    0002028614
    
      us-gaap:CommonStockMember

    2024-06-30

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2024-06-30

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-06-30

    0002028614
    
      us-gaap:RetainedEarningsMember

    2024-06-30

    0002028614

    2024-06-30

    0002028614
    
      us-gaap:CommonStockMember

    2024-07-01
    2024-09-30

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2024-07-01
    2024-09-30

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-07-01
    2024-09-30

    0002028614
    
      us-gaap:RetainedEarningsMember

    2024-07-01
    2024-09-30

    0002028614
    
      us-gaap:CommonStockMember

    2024-09-30

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2024-09-30

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-09-30

    0002028614
    
      us-gaap:RetainedEarningsMember

    2024-09-30

    0002028614

    2024-09-30

    0002028614
    
      dmaau:PublicSharesMember
      us-gaap:IPOMember

    2025-01-29
    2025-01-29

    0002028614
    
      dmaau:PublicSharesMember
      us-gaap:IPOMember

    2025-01-29

    0002028614
    
      us-gaap:IPOMember

    2025-01-